MedPath

Breaking up prolonged sitting with intermittent standing: acute effects in overweight inactive adults.

Not Applicable
Completed
Conditions
Type 2 diabetes
Overweight and obesity
Metabolic and Endocrine - Diabetes
Diet and Nutrition - Obesity
Registration Number
ACTRN12612000664842
Lead Sponsor
Baker IDI Heart and Diabetes Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion criteria includes: overweight or obesity (body mass index greater than or equal to 25kg/m2 but less than or equal to 45kg/m2) and English speaking

Exclusion Criteria

Exclusion is based on: of pregnancy; employment in a non-sedentary occupation (< 5 hours total sitting during the typical workday); currently watching < 3 hours of total screen (including television, computer or electronic games) time per day; regularly engaged in moderate-vigorous physical activity greater than or equal to 150min/week > 3 months; use of carbohydrate or lipid-lowering medication; greater than or equal to 5 previous vasovagal syncope episodes or epilepsy; known physical activity contraindications; major illness/injury (acute or chronic), smokers; orthostatic intolerance, and the use of aspirin or other anticoagulants.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postprandial plasma insulin levels (mean AUC). Plasma insulin concentrations will be assessed using standard testing equipment at an outsourced medical laboratory.[Blood insulin levels will be measured every hour for determination of the mean AUC. The mean AUC will be determined at day 7 and day 14 following study enrolment.];Postprandial plasma glucose levels (mean area under the curve [AUC]). Plasma glucose concentrations will be assessed using standard testing equipment at an outsourced medical laboratory.[Blood glucose levels will be measured every hour for determination of the mean AUC. The mean AUC will be determined at day 7 and day 14 following study enrolment.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath